Episode

The future of immunotherapy → are surgeons obsolete soon? with Jeroen Dekervel

Podcast
UEG Podcast
Published
Jan 13, 2026
Duration seconds
2400
Processing state
not_requested
Canonical source
https://ueg-talks-podcast.podigee.io/66-new-episode
Audio
https://audio.podigee-cdn.net/2300086-m-34167d6711ed859db44fdbf36c635ba9.mp3?source=feed
JSON
/v1/public/podcasts/ueg-podcast-6404464/episodes/the-future-of-immunotherapy-are-surgeons-obsolete-soon-with-jeroen-dekervel
Markdown
/podcast/ueg-podcast-6404464/the-future-of-immunotherapy-are-surgeons-obsolete-soon-with-jeroen-dekervel.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/ueg-podcast-6404464/episodes/the-future-of-immunotherapy-are-surgeons-obsolete-soon-with-jeroen-dekervel/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/ueg-podcast-6404464/the-future-of-immunotherapy-are-surgeons-obsolete-soon-with-jeroen-dekervel.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Immunotherapy might be revolutionising the way we fight GI cancers. In our latest episode, we dive into how this innovative treatment is changing patient outcomes and the role it plays in cancer management. To discuss this, we talked to Jeroen Dekervel, gastroenterologist and oncologist at the UZ Leuven in Belgium. Our host, Pradeep Mundre guides us through the conversation about how tumours develop a resistance to chemotherapy, the quality of life for oncological patients, and why the term "palliative treatment" for cancer patients could use an update.